Lutonix Inc. Announces $20 Million Series B Financing

Lutonix announced the close of a $20 million Series B financing. Lutonix is a medical device company
focused on drug coated balloon
angioplasty technology for the treatment and prevention of coronary and
peripheral artery stenosis caused by atherosclerosis. Lutonix’s drug coated
balloon technology is anticipated to enhance therapeutic options for
patients who are candidates for conventional therapies such as balloon
angioplasty [...]

Biotech Committed Equity Financing Facility

I can’t tell you why this seems to be the year of CEFFs (committed equity financing facility) but it can’t be argued otherwise. As you can see from the google news hist-trend-o-graph, press releases with CEFF in them are on pace to hit an all time high in 2008.

Basically, private investment firms (Kingsbridge Capital [...]

Biomed Funding Roudup: Week Ending 8.1.08

ReGen Biologics Closes $2.5 Million Private Placement and Announces New 510(k) Submission to the FDA
ReGen Biologics is an orthopedic products company that develops, manufactures and markets innovative tissue growth and repair products. The recently filed 510(k) seeks clearance of a collagen scaffold device for reinforcement and repair of meniscus tissue.
Biolex Therapeutics Adds $10.5 Million in [...]

Memorial Weekend Financing

I was always under the impression that the best time to release news you didn’t want anyone to fuss about was the Friday before a long weekend.
Somaxon Pharmaceuticals, Inc. Secures up to $65 Million in Financing
Somaxon Pharmaceuticals, Inc. announced that it has entered into a $15 million secured loan agreement with Oxford Finance Corporation and Silicon [...]